Paloma Silva de Souza

Variation of MDR proteins expression and activity levels according to clinical status and evolution of CML patients

Flavia da Cunha Vasconcelos, Karina L. Silva, Paloma Silva de Souza et al. · Cytometry Part B Clinical Cytometry · 2010 · 45 citations

Mixed-phenotype Acute Leukemia, Immunology, Pathology +16

Modeling intrinsic heterogeneity and growth of cancer cells

James M. Greene, Doron Levy, King Leung Fung et al. · Journal of Theoretical Biology · 2014 · 39 citations

Tumor Heterogeneity, Biological Microenvironments, Cell Growth +6

XIAP and P-glycoprotein co-expression is related to imatinib resistance in chronic myeloid leukemia cells

Karina Lani Silva, Paloma Silva de Souza, Gabriela Nestal de Moraes et al. · Leukemia Research · 2013 · 38 citations

The Interface between BCR-ABL-Dependent and -Independent Resistance Signaling Pathways in Chronic Myeloid Leukemia

Gabriela Nestal de Moraes, Paloma Silva de Souza, Fernanda Costas et al. · Leukemia Research and Treatment · 2012 · 37 citations · Full text

Imatinib Resistance, Tumor Biology, Chronic Myeloid Leukemia +14

Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type

Paloma Silva de Souza, André L. S. Cruz, João P. B. Viola et al. · Cancer Science · 2014 · 34 citations · Full text

Oncogenic Pathways, Biological Microenvironments, Multidrug Resistance +17